AIF1 and stroke disorder: The PBM treatment suppressed the expression of Iba‐1+ (105.41 ± 6.10% vs 130.41 ± 8.24%, stroke/PBM and stroke/control, respectively, p < 0.05 (p = 0.012); Figure 7c).